JP2008517953A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008517953A5 JP2008517953A5 JP2007538227A JP2007538227A JP2008517953A5 JP 2008517953 A5 JP2008517953 A5 JP 2008517953A5 JP 2007538227 A JP2007538227 A JP 2007538227A JP 2007538227 A JP2007538227 A JP 2007538227A JP 2008517953 A5 JP2008517953 A5 JP 2008517953A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- sequence
- antisense
- pharmaceutical composition
- oligonucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US62320604P | 2004-10-29 | 2004-10-29 | |
| US60/623,206 | 2004-10-29 | ||
| PCT/CA2005/001656 WO2006045202A1 (en) | 2004-10-29 | 2005-10-27 | Antisense oligonucleotides for treating allergy and neoplastic cell proliferation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008517953A JP2008517953A (ja) | 2008-05-29 |
| JP2008517953A5 true JP2008517953A5 (enExample) | 2008-12-11 |
| JP5314283B2 JP5314283B2 (ja) | 2013-10-16 |
Family
ID=36226992
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007538227A Expired - Fee Related JP5314283B2 (ja) | 2004-10-29 | 2005-10-27 | アレルギーおよび新生物細胞増殖を治療するための、アンチセンスオリゴヌクレオチド |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US8119790B2 (enExample) |
| EP (1) | EP1812075B1 (enExample) |
| JP (1) | JP5314283B2 (enExample) |
| CN (1) | CN101087623B (enExample) |
| AU (1) | AU2005299218B2 (enExample) |
| BR (1) | BRPI0517387A8 (enExample) |
| CA (1) | CA2584457C (enExample) |
| ES (1) | ES2450929T3 (enExample) |
| MX (1) | MX2007005083A (enExample) |
| NZ (1) | NZ554723A (enExample) |
| RU (1) | RU2416412C2 (enExample) |
| WO (1) | WO2006045202A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2285961A4 (en) | 2008-05-15 | 2012-10-17 | Topigen Pharmaceuticals Inc | OLIGONUCLEOTIDES FOR THE TREATMENT OF INFLAMMATION AND NEOPLASTIC CELL REPRODUCTION |
| ES2625689T3 (es) | 2010-04-29 | 2017-07-20 | Ionis Pharmaceuticals, Inc. | Modulación de la expresión de transtiretina |
| JP2014511181A (ja) * | 2011-02-24 | 2014-05-15 | ファーマキシス リミテッド | キメラ骨格および２−アミノ−２’−デオキシアデノシンを有するオリゴヌクレオチド阻害剤 |
| US9901079B2 (en) | 2011-08-18 | 2018-02-27 | New York University | Inhibition of oncogenic kras-induced GM-CSF production and function |
| WO2015066262A1 (en) * | 2013-11-04 | 2015-05-07 | Trustees Of Dartmouth College | Methods for preventing toxicity of adoptive cell therapy |
| HK1255922A1 (zh) | 2015-11-04 | 2019-09-06 | Astrazeneca Ab | 二肽基肽酶-4和骨膜素作为嗜酸性粒细胞疾病中嗜酸性粒细胞靶向治疗药物临床反应的预测因子 |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3337530A (en) | 1965-09-20 | 1967-08-22 | Upjohn Co | Dinucleoside 3', 5' -and 2', 5'-phosphates containing one 7-deazapurin riboside moiety |
| US4880635B1 (en) | 1984-08-08 | 1996-07-02 | Liposome Company | Dehydrated liposomes |
| US4921757A (en) | 1985-04-26 | 1990-05-01 | Massachusetts Institute Of Technology | System for delayed and pulsed release of biologically active substances |
| US4920016A (en) | 1986-12-24 | 1990-04-24 | Linear Technology, Inc. | Liposomes with enhanced circulation time |
| JPH0825869B2 (ja) | 1987-02-09 | 1996-03-13 | 株式会社ビタミン研究所 | 抗腫瘍剤包埋リポソ−ム製剤 |
| US4911928A (en) | 1987-03-13 | 1990-03-27 | Micro-Pak, Inc. | Paucilamellar lipid vesicles |
| US4917951A (en) | 1987-07-28 | 1990-04-17 | Micro-Pak, Inc. | Lipid vesicles formed of surfactants and steroids |
| US5646265A (en) | 1990-01-11 | 1997-07-08 | Isis Pharmceuticals, Inc. | Process for the preparation of 2'-O-alkyl purine phosphoramidites |
| US5872242A (en) | 1992-10-05 | 1999-02-16 | Isis Pharmaceuticals, Inc. | Antisense oligonucleotide inhibition of ras |
| GB9301000D0 (en) | 1993-01-20 | 1993-03-10 | Glaxo Group Ltd | Chemical compounds |
| US6806061B1 (en) * | 1995-01-19 | 2004-10-19 | Children's Medical Center Corporation | G protein-coupled receptor gene and methods of use therefor |
| US5874211A (en) | 1995-04-13 | 1999-02-23 | Incyte Pharmaceuticals, Inc. | Chemokine expressed in eosinophils |
| FR2734147B1 (fr) | 1995-05-19 | 1997-10-10 | Klein Jean Michel | Dispositif d'osteosynthese implantable |
| US6825174B2 (en) | 1995-06-07 | 2004-11-30 | East Carolina University | Composition, formulations & method for prevention & treatment of diseases and conditions associated with bronchoconstriction, allergy(ies) & inflammation |
| US6025339A (en) | 1995-06-07 | 2000-02-15 | East Carolina University | Composition, kit and method for treatment of disorders associated with bronchoconstriction and lung inflammation |
| FR2742156A1 (fr) | 1995-12-06 | 1997-06-13 | Sanofi Sa | Polypeptide recepteur de l'il-13 |
| US6265184B1 (en) | 1995-12-20 | 2001-07-24 | Icos Corporation | Polynucleotides encoding chemokine receptor 88C |
| WO1997023244A1 (en) | 1995-12-22 | 1997-07-03 | Smithkline Beecham Corporation | Use of antisene oligodeoxynucleotides to produce truncated proteins |
| AUPN780096A0 (en) | 1996-01-30 | 1996-02-22 | Medvet Science Pty. Ltd. | Cytokine antagonists and agonists |
| EP1012190A4 (en) | 1996-04-26 | 2004-04-28 | Merck & Co Inc | Eotaxin receptor from eosinophils |
| JP2000510690A (ja) | 1996-04-26 | 2000-08-22 | インサイト・ファーマスーティカルズ・インコーポレイテッド | 哺乳類混合リンパ球受容体、ケモカイン受容体（ｍｍｌｒ―ｃｃｒ） |
| US5807708A (en) | 1996-07-30 | 1998-09-15 | Millennium Pharmaceuticals, Inc. | Conservin nucleic acid molecules and compositions |
| EP1019065A4 (en) | 1997-09-17 | 2002-02-20 | Univ East Carolina | NUCLEIC ACIDS HYBRIDIZING TO MULTIPLE TARGETS, THEIR PREPARATION, COMPOSITIONS, FORMULATION, KITS AND APPLICATIONS |
| CA2235420A1 (en) * | 1998-06-17 | 1999-12-17 | Paolo Renzi | Antisense oligonucleotides for treating or preventing atopic diseases and neoplastic cell proliferation |
| ATE346918T1 (de) | 1998-06-19 | 2006-12-15 | Univ Mcgill | Auf beta-arabinose, und dessen analogen, basierte antisense oligonukleotide |
| HK1042706A1 (zh) | 1998-08-03 | 2002-08-23 | 东卡罗来纳大学 | 低腺苷反义寡核苷酸制剂、组合物、试剂盒及处理 |
| US6175004B1 (en) | 1998-09-01 | 2001-01-16 | Isis Pharmaceuticals, Inc. | Process for the synthesis of oligonucleotides incorporating 2-aminoadenosine |
| AU4031700A (en) | 1999-04-06 | 2000-11-02 | East Carolina University | Low adenosine anti-sense oligonucleotide, compositions, kit and method for treatment of airway disorders associated with bronchoconstriction, lung inflammation,allergy(ies) and surfactant depletion |
| CA2419563C (en) | 2000-09-06 | 2018-03-20 | Mcgill University | Chimeric antisense of arabinofuranose analogue and deoxyribose nucleotides |
| US20020151064A1 (en) * | 2001-02-07 | 2002-10-17 | Children's Hospital Medical Center | Regulation of CCR3 expression |
| PT1406667E (pt) | 2001-07-06 | 2008-05-23 | Topigen Pharmaceuticals Inc | Métodos para aumentar a eficácia in vivo de oligonucleótidos e a inibição da inflamação em mamíferos |
| JP2005508634A (ja) | 2001-10-29 | 2005-04-07 | マクギル・ユニヴァーシティ | 非環式リンカー含有オリゴヌクレオチド及びその用途 |
| DK1470144T3 (da) | 2002-02-01 | 2009-04-06 | Univ Mcgill | Oligonukleotider omfattende alternerende segmenter og anvendelser deraf |
-
2005
- 2005-10-27 MX MX2007005083A patent/MX2007005083A/es active IP Right Grant
- 2005-10-27 EP EP05802169.2A patent/EP1812075B1/en not_active Expired - Lifetime
- 2005-10-27 AU AU2005299218A patent/AU2005299218B2/en not_active Ceased
- 2005-10-27 RU RU2007119777/15A patent/RU2416412C2/ru not_active IP Right Cessation
- 2005-10-27 US US11/666,647 patent/US8119790B2/en not_active Expired - Fee Related
- 2005-10-27 NZ NZ554723A patent/NZ554723A/en not_active IP Right Cessation
- 2005-10-27 CN CN2005800448619A patent/CN101087623B/zh not_active Expired - Fee Related
- 2005-10-27 JP JP2007538227A patent/JP5314283B2/ja not_active Expired - Fee Related
- 2005-10-27 WO PCT/CA2005/001656 patent/WO2006045202A1/en not_active Ceased
- 2005-10-27 CA CA2584457A patent/CA2584457C/en not_active Expired - Fee Related
- 2005-10-27 ES ES05802169.2T patent/ES2450929T3/es not_active Expired - Lifetime
- 2005-10-27 BR BRPI0517387A patent/BRPI0517387A8/pt not_active Application Discontinuation
-
2011
- 2011-11-21 US US13/301,183 patent/US8202851B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010534684A5 (enExample) | ||
| JP2009539367A5 (enExample) | ||
| JP2009530319A5 (enExample) | ||
| JP2008546390A5 (enExample) | ||
| JP2008525033A5 (enExample) | ||
| JP2022501055A5 (enExample) | ||
| JP2016116520A5 (enExample) | ||
| JP2012505657A5 (enExample) | ||
| JP2011512326A5 (enExample) | ||
| JP2021506238A5 (enExample) | ||
| JP2006149395A5 (enExample) | ||
| JP2006500958A5 (enExample) | ||
| JP2015532097A5 (enExample) | ||
| JP2017070307A5 (enExample) | ||
| JP2008538183A5 (enExample) | ||
| JP2010166916A5 (enExample) | ||
| JP2018530530A5 (enExample) | ||
| JP2007075118A5 (enExample) | ||
| JP2010088434A5 (enExample) | ||
| Van Der Valk et al. | Genomic looping: a key principle of chromatin organization | |
| JP2004533246A5 (enExample) | ||
| JP2005237328A5 (enExample) | ||
| JP2011524745A5 (enExample) | ||
| Savage et al. | RNA-seq identifies a role for the PPARβ/δ inverse agonist GSK0660 in the regulation of TNFα-induced cytokine signaling in retinal endothelial cells | |
| JP2011521661A5 (enExample) |